CellGenix GmbH

6 articles about CellGenix GmbH

• CEVEC and CellGenix announce the launch of GMP-grade TGF-ß1 for cell and gene therapy applications

  12/19/2019

  CEVEC’s CAP®Go technology enables CellGenix to offer rh TGF-ß1 in preclinical and now also in GMP-grade quality, allowing a seamless transition from preclinical to clinical development and commercial manufacturing of cell therapy products

• CellGenix Appoints Dr. Udo Nirenberg as Vice President Quality Management and Member of the Management Team

  11/6/2018

  CellGeni is pleased to announce the appointment of Dr. Udo Nirenberg as Vice President of Quality Management and member of the management team.

• CellGenix Completed First Step of Facility Expansion to Stay on Top of the Increasing Demands for GMP Cell Culture Reagents

  6/21/2018

  CellGenix, successfully completed the first phase of its headquarters’ expansion.

• CellGenix Appoints Leading Experts To Scientific Advisory Board

  5/15/2017

• CellGenix Headquarters Expands To Meet The Increasing Demands For GMP Cell Culture Reagents

  2/21/2017

• CEVEC And CellGenix GmbH Sign Collaboration And License Agreement For CEVEC's Proprietary CAP Go Technology

  10/7/2015